\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 10, 2009 7:30 AM EST
\n\n \n Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 29, 2009 7:30 AM EDT
\n\n \n Xenomics, Inc. Files Suit against Sequenom, Inc. for Fraud - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 16, 2009 4:01 PM EDT
\n\n \n Axion Appoints Gary R. Anthony as Chief Financial Officer - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 06, 2009 7:30 AM EDT
\n\n \n Xenomics Appoints Bruce A. Huebner as Chief Executive Officer and Board Member - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 06, 2008 7:00 AM EST
\n\n \n [video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: JAVA, WTR, HUSQF, XNOM, ZVTK, INCL, AXPW - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Oct 29, 2007 8:03 AM EDT
\n\n \n Xenomics Announces License with Asuragen for NPM1 Leukemia Diagnostics - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Sep 17, 2007 8:01 AM EDT
\n\n \n Xenomics Announces Agreement with Ipsogen for Diagnostic Assays of Leukemia - PR Newswire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");